Anyone Else been called about thier salary?

[Anonymous]

Taken from the above link.

We're confident in the effectiveness of rivaroxaban in preventing strokes in patients with atrial fibrillation and look forward to presenting our data to address the FDA's questions on Thursday," said Johnson & Johnson spokesman Ernie Kniewitz. "In our book, we've laid out a lot of points that support the effectiveness of rivaroxaban."

 

[Anonymous]

Also taken from the above link? This drug aint comin out soon.

"We now see a first-time approval as being unlikely," Jerffries Research analyst Jeffrey Holford wrote to investors. He noted the staff comments "point to poor clinical trial design."

 

[Anonymous]

Taken from the above link.

We're confident in the effectiveness of rivaroxaban in preventing strokes in patients with atrial fibrillation and look forward to presenting our data to address the FDA's questions on Thursday," said Johnson & Johnson spokesman Ernie Kniewitz. "In our book, we've laid out a lot of points that support the effectiveness of rivaroxaban."

LOL! You hang your hat on what a J&J "spokesman" says vs what the FDA review panels says.

Wow! Just Wow!

Dead!

X X
-
----

 

[Anonymous]

I spoke with a recruiter this week as well for an initial interview as the 2nd person for this territory. The recruiter stated that they did indeed select 1 candidate already but don't wish to make the official offer to that person until they have selected the 2nd candidate and both offers are set forth at the same time. Recruiter stated that the initial date of Sept 2nd may be difficult to achieve.

Are you saying there will be 2 top candidates offered positions per territory? I was given a call about how salary calculated and that I would definitely be getting a call. In that conversation and previous informed 2 top candidates. Hope this doesn't mean they are going to select 1 of the 2.